Macular disease

Eight Australian researchers are taking their projects to the next level with a share of more than $1 million in...

As part of Macula Month this May, Insight examines drug development programs that could significantly alter the late-stage AMD therapy...

Australia’s first clinical trials of an investigational gene therapy for dry age-related macular degeneration (AMD) has commenced at the Centre...

An independent expert panel has recommended Novartis' treatment Beovu be subsidised through the Pharmaceutical Benefits Scheme (PBS) for neovascular age-related...

Two years since the KeepSight launch, Insight asks what measurable difference this once-in-a-generation program is making to those living with...

A new diabetic eye clinic for children in Western Australia, which opened last month, is part of the Lions Eye Institute's first major...

Nova Eye Medical has announced positive five-year follow-up data from a sub-study analysis of the multi-centre LEAD trial for its...

The Australian government spent more than $610 million on anti-VEGF treatments during the past year, with aflibercept (Eylea) leapfrogging a...

A clinical trial is under way in Australia for a novel eye drop treatment for retinal vascular diseases that could...

Researchers from the Centre for Eye Research Australia and University of Melbourne have developed a world-first survey to gather the...